Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate and differentiate themselves into various tissues cells. Stem cells, commonly encountered in clinical or preclinical stages, are largely classified into embryonic, adult, and induced pluripotent stem cells. Recently, stem cell transplantation has been frequently applied to the treatment of pain as an alternative or promising approach for the treatment of severe osteoarthritis, neuropathic pain, and intractable musculoskeletal pain which do not respond to conventional medicine. The main idea of applying stem cells to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathic pain. Even though various differentiation capacities of stem cells are reported, there is not enough knowledge and technique to control the differentiation into desired tissues in vivo. Even though the use of stem cells is still in the very early stages of clinical use and raises complicated ethical problems, the future of stem cells therapies is very bright with the help of accumulating evidence and technology.
Keywords: Adult Stem Cells; Aging; Cell Differentiation; Embryonic Stem Cells; Induced Pluripotent Stem Cells; Musculoskeletal Pain; Nerve Growth Factors; Neuralgia; Osteoarthritis.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Adult stem cell as new advanced therapy for experimental neuropathic pain treatment.Biomed Res Int. 2014;2014:470983. doi: 10.1155/2014/470983. Epub 2014 Aug 13. Biomed Res Int. 2014. PMID: 25197647 Free PMC article. Review.
Stem cells and cardiac repair: a critical analysis.J Cardiovasc Transl Res. 2008 Mar;1(1):41-54. doi: 10.1007/s12265-007-9008-7. Epub 2008 Jan 31. J Cardiovasc Transl Res. 2008. PMID: 20559957 Review.
Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine.Br Biotechnol J. 2013 Oct 1;3(4):424-457. doi: 10.9734/BBJ/2013/4309#sthash.6D8Rulbv.dpuf. Br Biotechnol J. 2013. PMID: 24926434 Free PMC article.
Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(6):1-57. Epub 2005 Apr 1. Ont Health Technol Assess Ser. 2005. PMID: 23074475 Free PMC article.
Efficient derivation of human neuronal progenitors and neurons from pluripotent human embryonic stem cells with small molecule induction.J Vis Exp. 2011 Oct 28;(56):e3273. doi: 10.3791/3273. J Vis Exp. 2011. PMID: 22064669 Free PMC article.